Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Smith & Nephew Snats (SNN)
NYSE:SNN
RESEARCH TOOLSreports
Holding SNN?
Track your performance easily
SNN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.65 - $31.72
Previous CloseN/A
Volume262.39K
Average Volume (3M)868.40K
Market Cap
$10.90B
Enterprise Value$13.89B
Total Cash (Recent Filing)$100.00M
Total Debt (Recent Filing)$1.56B
Price to Earnings (P/E)35.6
Beta0.70
Next Earnings
Feb 25, 2025EPS Estimate
0.92Last Dividend Ex-Date
Oct 04, 2024Dividend Yield2.92%
Share Statistics
EPS (TTM)0.70
Shares Outstanding437,193,850
10 Day Avg. Volume1,025,936
30 Day Avg. Volume868,401
Standard Deviation0.08
R-Squared0.29
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.91
Price to Cash Flow (P/CF)22.70
P/FCF Ratio39.90
Enterprise Value/Market Cap1.27
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.64
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$27.14Price Target Upside8.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Smith & Nephew Snats News
PremiumCompany Announcements
Smith+Nephew Appoints Sybella Stanley as Non-Executive Director
PremiumCompany Announcements
Smith & Nephew Announces Share Capital Structure
PremiumCompany Announcements
Smith & Nephew CFO Purchases Significant Shares, Boosting Investor Confidence
PremiumCompany Announcements
Smith & Nephew’s Shareholding Shift: BlackRock’s Increased Stake
Ownership Overview
―
Insiders
1.05% Mutual Funds
0.06% Other Institutional Investors
98.76% Public Companies and
Individual Investors
SNN FAQ
What was Smith & Nephew Snats’s price range in the past 12 months?
Smith & Nephew Snats lowest stock price was $23.65 and its highest was $31.72 in the past 12 months.
What is Smith & Nephew Snats’s market cap?
Smith & Nephew Snats’s market cap is $10.90B.
When is Smith & Nephew Snats’s upcoming earnings report date?
Smith & Nephew Snats’s upcoming earnings report date is Feb 25, 2025 which is in 38 days.
How were Smith & Nephew Snats’s earnings last quarter?
Smith & Nephew Snats released its earnings results on Aug 01, 2024. The company reported $0.756 earnings per share for the quarter, missing the consensus estimate of $0.786 by -$0.03.
Is Smith & Nephew Snats overvalued?
According to Wall Street analysts Smith & Nephew Snats’s price is currently Undervalued.
Does Smith & Nephew Snats pay dividends?
Smith & Nephew Snats pays a Semiannually dividend of $0.724 which represents an annual dividend yield of 2.92%. See more information on Smith & Nephew Snats dividends here
What is Smith & Nephew Snats’s EPS estimate?
Smith & Nephew Snats’s EPS estimate is 0.92.
How many shares outstanding does Smith & Nephew Snats have?
Smith & Nephew Snats has 437,193,850 shares outstanding.
What happened to Smith & Nephew Snats’s price movement after its last earnings report?
Smith & Nephew Snats reported an EPS of $0.756 in its last earnings report, missing expectations of $0.786. Following the earnings report the stock price went up 6.872%.
Which hedge fund is a major shareholder of Smith & Nephew Snats?
Among the largest hedge funds holding Smith & Nephew Snats’s share is Brandes Investment Partners LP. It holds Smith & Nephew Snats’s shares valued at 38M.
---
Smith & Nephew Snats Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.14 (8.34% Upside)
$27.14 (8.34% Upside)
Blogger Sentiment
Bullish
SNN Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 139.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.1%
Last 30 Days ▲ 7.2%
Last 30 Days ▲ 7.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.60%
12-Months-Change
Fundamentals
Return on Equity
5.83%
Trailing 12-Months
Asset Growth
7.09%
Trailing 12-Months
Company Description
Smith & Nephew Snats
Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It offers the following products and services: sports medicine joint repair; arthroscopic enabling technologies; trauma and extremities; other surgical businesses; knee and hip implants, and advanced wound care, wound bioactives, and wound devices. It operates through the United Kingdom, United States of America, and Other geographical segments. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.
---
SNN Company Deck
---
SNN Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive overall sentiment, driven by strong revenue growth, margin achievement, and significant advancements in Sports Medicine, ENT, and Advanced Wound Management. However, challenges in U.S. Reconstruction and the impact of China VBP present notable headwinds.Read More>---
SNN Stock 12 Month Forecast
Average Price Target
$27.14
▲(8.34% Upside)
Technical Analysis
Medtronic
―
Stryker
―
Zimmer Biomet Holdings
―
Baxter International
―
Globus Medical
―
Edwards Lifesciences
―
Best Analysts Covering SNN
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-12.70%
assigned a buy rating 3 months ago
Copying Julien Ouaddour's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -12.70% per trade.
---